View Clinical Trial (Medical Research Study)

Testosterone for Penile Rehab After Radical Prostatectomy - NCT00848497-77030(Clinical Trial 273532)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Houston
State:  
TX
Zip Code: 77030
Conditions: Low Testosterone Levels - Erectile Dysfunction
Purpose: The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone gel) 5 g per day plus Viagra 25 mg every night and the other will receive Placebo-Testim® 5 g per day plus Viagra 25 mg every night. Subjects will begin drug treatment 3 months after the initial screening visit and will take study drug for 3 months only. Participation will end at the end of the 6-month visit.
Study summary:
Criteria: Inclusion Criteria: - Males, 18 years of age or older, with low testosterone levels. - Must have undergone a bilateral nerve sparing radical prostatectomy. - Nadir PSA values should be less than 0.01 ng/ml on two consecutive occasions separated by 4 weeks at the start of treatment. - Must give informed consent. - Must be willing to complete follow-up visits. Exclusion Criteria: - Testosterone level greater than 300 ng/ dl - Hemoglobin level greater than 18 ng/dl. - Positive surgical margins or evidence of residual prostate cancer after surgery. - Clinically suspected advanced disease or actual evidence of metastatic prostate cancer. - Primary Gleason Grade greater than 3 or secondary Gleason Grade greater than 4 in the final pathologic specimen will be excluded. - Taking nitrates or with contraindications to the use of Viagra or androgen therapy will be excluded. - Known hypersensitivity to any component of the tablet will be excluded.
Study is available at: Baylor College of Medicine
Houston, TX 77030
United States

Primary Contact:
Sharon Harrison
Email: sharons@bcm.edu
Phone: 713-798-2240
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.